Overview

We are a real estate investment trust ("REIT") that commenced operations in 1986. We invest in healthcare and human service related facilities currently including acute care hospitals, behavioral health care hospitals, specialty hospitals, free-standing emergency departments, childcare centers and medical/office buildings. As of February 26, 2020, we have seventy-one real estate investments or commitments in twenty states consisting of:

• seven hospital facilities consisting of three acute care, one behavioral

health care (currently under construction), one rehabilitation (currently


        vacant) and two sub-acute (one of which is currently vacant);


  • four free-standing emergency departments ("FEDs");

• fifty-six medical/office buildings, including five owned by unconsolidated


        LLCs/LPs, one of which is currently under construction, and;


  • four preschool and childcare centers.

Forward Looking Statements



This report contains "forward-looking statements" that reflect our current
estimates, expectations and projections about our future results, performance,
prospects and opportunities. Forward-looking statements include, among other
things, information concerning our possible future results of operations,
business and growth strategies, financing plans, expectations that regulatory
developments or other matters will not have a material adverse effect on our
business or financial condition, our competitive position and the effects of
competition, the projected growth of the industry in which we operate, and the
benefits and synergies to be obtained from our completed and any future
acquisitions, and statements of our goals and objectives, and other similar
expressions concerning matters that are not historical facts. Words such as
"may," "will," "should," "could," "would," "predicts," "potential," "continue,"
"expects," "anticipates," "future," "intends," "plans," "believes," "estimates,"
"appears," "projects" and similar expressions, as well as statements in future
tense, identify forward-looking statements.

Forward-looking statements should not be read as a guarantee of future
performance or results, and will not necessarily be accurate indications of the
times at, or by which, such performance or results will be achieved.
Forward-looking information is based on information available at the time and/or
our good faith belief with respect to future events, and is subject to risks and
uncertainties that could cause actual performance or results to differ
materially from those expressed in the statements. Such factors include, among
other things, the following:

• a substantial portion of our revenues are dependent upon one operator,

Universal Health Services, Inc. ("UHS"), which comprised approximately

31%, 30% and 32% of our consolidated revenues for the years ended December

31, 2019, 2018 and 2017, respectively. We cannot assure you that

subsidiaries of UHS will renew the leases on our three acute care

hospitals (two of which are scheduled to expire in December, 2021 and one

of which is scheduled to expire in December, 2026) and two FEDs at

existing lease rates or fair market value lease rates. In addition, if

subsidiaries of UHS exercise their options to purchase the respective


        leased hospital facilities and FEDs upon expiration of the lease terms,
        our future revenues and results of operations could decrease if we were

unable to earn a favorable rate of return on the sale proceeds received,


        as compared to the rental revenue currently earned pursuant to these
        leases;

• in certain of our markets, the general real estate market has been

unfavorably impacted by increased competition/capacity and decreases in


        occupancy and rental rates which may adversely impact our operating
        results and the underlying value of our properties;

• a number of legislative initiatives have recently been passed into law

that may result in major changes in the health care delivery system on a

national or state level to the operators of our facilities, including UHS.

No assurances can be given that the implementation of these new laws will

not have a material adverse effect on the business, financial condition or

results of operations of our operators;

• the potential indirect impact of the Tax Cuts and Jobs Act of 2017 (the

"2017 Tax Act"), signed into law on December 22, 2017, which makes

significant changes to corporate and individual tax rates and calculation

of taxes, which could potentially impact our tenants and jurisdictions,


        both positively and negatively, in which we do business, as well as the
        overall investment thesis for REITs;

• a subsidiary of UHS is our Advisor and our officers are all employees of a


        wholly-owned subsidiary of UHS, which may create the potential for
        conflicts of interest;




                                       31

--------------------------------------------------------------------------------

• lost revenues resulting from the exercise of purchase options, lease

expirations and renewals and other restructuring (see Item 2. Management's

Discussion and Analysis of Financial Condition and Results of

Operations-Hospital Leases, for additional disclosure related to lease

expirations and subsequent vacancies that occurred during the second and

third quarters of 2019 on two hospital facilities that, on a combined

basis, comprised approximately 2% of our consolidated revenues during each

of the years ended December 31, 2018 and 2017);

• our ability to continue to obtain capital on acceptable terms, including

borrowed funds, to fund future growth of our business;

• the outcome and effects of known and unknown litigation, government

investigations, and liabilities and other claims asserted against us, UHS

or the other operators of our facilities. UHS and its subsidiaries are

subject to pending legal actions, purported shareholder class actions and

shareholder derivative cases, governmental investigations and regulatory

actions and the effects of adverse publicity relating to such matters.


        Since UHS comprised approximately 31% of our consolidated revenues during
        the year ended December 31, 2019, and since a subsidiary of UHS is our

Advisor, you are encouraged to obtain and review the disclosures contained

in the Legal Proceedings section of Universal Health Services, Inc.'s

Forms 10-Q and 10-K, as publicly filed with the Securities and Exchange

Commission. Those filings are the sole responsibility of UHS and are not

incorporated by reference herein;

• failure of UHS or the other operators of our hospital facilities to comply

with governmental regulations related to the Medicare and Medicaid

licensing and certification requirements could have a material adverse

impact on our future revenues and the underlying value of the property;

• the potential unfavorable impact on our business of deterioration in

national, regional and local economic and business conditions, including a

worsening of credit and/or capital market conditions, which may adversely


        affect our ability to obtain capital which may be required to fund the
        future growth of our business and refinance existing debt with near term
        maturities;


    •   a deterioration in general economic conditions which could result in

increases in the number of people unemployed and/or insured and likely

increase the number of individuals without health insurance; as a result,

the operators of our facilities may experience decreases in patient

volumes which could result in decreased occupancy rates at our medical

office buildings;

• a worsening of the economic and employment conditions in the United States

could materially affect the business of our operators, including UHS,

which may unfavorably impact our future bonus rentals (on the UHS hospital

facilities) and may potentially have a negative impact on the future lease

renewal terms and the underlying value of the hospital properties;

• real estate market factors, including without limitation, the supply and

demand of office space and market rental rates, changes in interest rates

as well as an increase in the development of medical office condominiums

in certain markets;

• the impact of property values and results of operations of severe weather

conditions, including the effects of hurricanes;

• government regulations, including changes in the reimbursement levels

under the Medicare and Medicaid programs;

• the issues facing the health care industry that affect the operators of

our facilities, including UHS, such as: changes in, or the ability to

comply with, existing laws and government regulations; unfavorable changes


        in the levels and terms of reimbursement by third party payors or
        government programs, including Medicare (including, but not limited to,
        the potential unfavorable impact of future reductions to Medicare

reimbursements resulting from the Budget Control Act of 2011, as discussed

below) and Medicaid (most states have reported significant budget deficits

that have, in the past, resulted in the reduction of Medicaid funding to

the operators of our facilities, including UHS); demographic changes; the

ability to enter into managed care provider agreements on acceptable

terms; an increase in uninsured and self-pay patients which unfavorably

impacts the collectability of patient accounts; decreasing in-patient

admission trends; technological and pharmaceutical improvements that may


        increase the cost of providing, or reduce the demand for, health care,
        and; the ability to attract and retain qualified medical personnel,
        including physicians;

• pending limits for most federal agencies and programs aimed at reducing

budget deficits by $917 billion between 2012 and 2021, according to a

report released by the Congressional Budget Office. Among its other

provisions, the law established a bipartisan Congressional committee,

known as the Joint Select Committee on Deficit Reduction (the "Joint

Committee"), which was tasked with making recommendations aimed at

reducing future federal budget deficits by an additional $1.5 trillion


        over 10 years. The Joint Committee was unable to reach an agreement by the
        November 23, 2011 deadline and, as a result, across-the-board cuts to

discretionary, national defense and Medicare spending were implemented on

March 1, 2013 resulting in Medicare payment reductions of up to 2% per
        fiscal year with a uniform percentage reduction across all Medicare
        programs. The Bipartisan Budget Act of 2015, enacted on November 2, 2015,




                                       32

--------------------------------------------------------------------------------



        continued the 2% reductions to Medicare reimbursement imposed under the
        2011 Act. We cannot predict whether Congress will restructure the

implemented Medicare payment reductions or what other federal budget

deficit reduction initiatives may be proposed by Congress going

forward. We also cannot predict the effect these enactments will have on

the operators of our properties (including UHS), and thus, our business;

• an increasing number of legislative initiatives have been passed into law


        that may result in major changes in the health care delivery system on a
        national or state level. Legislation has already been enacted that has
        eliminated the penalty for failing to maintain health coverage that was
        part of the original Legislation. President Trump has already taken

executive actions: (i) requiring all federal agencies with authorities and

responsibilities under the Legislation to "exercise all authority and

discretion available to them to waiver, defer, grant exemptions from, or

delay" parts of the Legislation that place "unwarranted economic and

regulatory burdens" on states, individuals or health care providers; (ii)

the issuance of a final rule in June, 2018 by the Department of Labor to

enable the formation of association health plans that would be exempt from

certain Legislation requirements such as the provision of essential health

benefits; (iii) the issuance of a final rule in August, 2018 by the

Department of Labor, Treasury, and Health and Human Services to expand the

availability of short-term, limited duration health insurance, (iv)

eliminating cost-sharing reduction payments to insurers that would

otherwise offset deductibles and other out-of-pocket expenses for health

plan enrollees at or below 250 percent of the federal poverty level; (v)

relaxing requirements for state innovation waivers that could reduce

enrollment in the individual and small group markets and lead to

additional enrollment in short-term, limited duration insurance and

association health plans; (vi) the issuance of a final rule in June, 2019

by the Departments of Labor, Treasury, and Health and Human Services that

would incentivize the use of health reimbursement arrangements by

employers to permit employees to purchase health insurance in the

individual market, and; (vii) directing the issuance of federal rulemaking


        by executive agencies to increase transparency of healthcare price and
        quality information. The uncertainty resulting from these Executive Branch
        policies has led to reduced Exchange enrollment in 2018 and 2019 and is
        expected to further worsen the individual and small group market risk
        pools in future years. It is also anticipated that these and future
        policies may create additional cost and reimbursement pressures on
        hospitals, including ours. In addition, while attempts to repeal the

entirety of the Affordable Care Act ("ACA") have not been successful to

date, a key provision of the ACA was repealed as part of the Tax Cuts and

Jobs Act and on December 14, 2018, a federal U.S. District Court Judge in

Texas ruled the entire ACA is unconstitutional. That ruling was stayed and

has been appealed. On December 18, 2019, the 5th Circuit Court of Appeals

voted 2-1 to strike down the ACA individual mandate as unconstitutional

and sent the case back to the U.S. District Court in Texas to determine


        which ACA provisions should be stricken with the mandate. It is likely
        this matter will ultimately be appealed to the U.S. Supreme Court. We are
        unable to predict the final outcome of this matter which has caused
        greater uncertainty regarding the future status of the ACA. If all or any
        parts of the ACA are ultimately found to be unconstitutional, it could
        have a material adverse effect on the business, financial condition and

results of operations of the operators of our properties, and, thus, our

business;

• there can be no assurance that if any of the announced or proposed changes

described above are implemented there will not be negative financial


        impact on the operators of our hospitals, which material effects may
        include a potential decrease in the market for health care services or a

decrease in the ability of the operators of our hospitals to receive

reimbursement for health care services provided which could result in a

material adverse effect on the financial condition or results of

operations of the operators of our properties, and, thus, our business;

• competition for properties include, but are not limited to, other REITs,

private investors and firms, banks and other companies, including UHS. In

addition, we may face competition from other REITs for our tenants;

• the operators of our facilities face competition from other health care

providers, including physician owned facilities and other competing

facilities, including certain facilities operated by UHS but the real

property of which is not owned by us. Such competition is experienced in

markets including, but not limited to, McAllen, Texas, the site of our

McAllen Medical Center, a 370-bed acute care hospital, and Riverside

County, California, the site of our Southwest Healthcare System-Inland

Valley Campus, a 130-bed acute care hospital;

• changes in, or inadvertent violations of, tax laws and regulations and


        other factors than can affect REITs and our status as a REIT;


    •   should we be unable to comply with the strict income distribution
        requirements applicable to REITs, utilizing only cash generated by
        operating activities, we would be required to generate cash from other
        sources which could adversely affect our financial condition;

• our ownership interest in five LLCs/LPs in which we hold non-controlling


        equity interests. In addition, pursuant to the operating and/or
        partnership agreements of the four LLCs/LPs in which we continue to hold
        non-controlling ownership interests, the third-party member and the Trust,

at any time, potentially subject to certain conditions, have the right to

make an offer ("Offering Member") to the other member(s) ("Non-Offering

Member") in which it either agrees to: (i) sell the entire ownership


        interest of the Offering Member to the Non-Offering Member ("Offer to
        Sell") at a price as




                                       33

--------------------------------------------------------------------------------

determined by the Offering Member ("Transfer Price"), or; (ii) purchase


        the entire ownership interest of the Non-Offering Member ("Offer to
        Purchase") at the equivalent proportionate Transfer Price. The
        Non-Offering Member has 60 to 90 days to either: (i) purchase the entire
        ownership interest of the Offering Member at the Transfer Price, or;
        (ii) sell its entire ownership interest to the Offering Member at the

equivalent proportionate Transfer Price. The closing of the transfer must

occur within 60 to 90 days of the acceptance by the Non-Offering Member;




  • fluctuations in the value of our common stock, and;


    •   other factors referenced herein or in our other filings with the
        Securities and Exchange Commission.


Given these uncertainties, risks and assumptions, you are cautioned not to place
undue reliance on such forward-looking statements. Our actual results and
financial condition, including the operating results of our lessees and the
facilities leased to subsidiaries of UHS, could differ materially from those
expressed in, or implied by, the forward-looking statements.

Forward-looking statements speak only as of the date the statements are made. We
assume no obligation to publicly update any forward-looking statements to
reflect actual results, changes in assumptions or changes in other factors
affecting forward-looking information, except as may be required by law. All
forward-looking statements attributable to us or persons acting on our behalf
are expressly qualified in their entirety by this cautionary statement.

Critical Accounting Policies and Estimates



The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires us to make estimates
and assumptions that affect the amounts reported in our consolidated financial
statements and accompanying notes.

We consider our critical accounting policies to be those that require us to make
significant judgments and estimates when we prepare our financial statements,
including the following:

Purchase Accounting for Acquisition of Investments in Real Estate: Purchase
accounting is applied to the assets and liabilities related to all real estate
investments acquired from third parties. In accordance with current accounting
guidance, we account for our property acquisitions as acquisitions of assets,
which requires the capitalization of acquisition costs to the underlying assets
and prohibits the recognition of goodwill or bargain purchase gains. The fair
value of the real estate acquired is allocated to the acquired tangible assets,
consisting primarily of land, building and tenant improvements, and identified
intangible assets and liabilities, consisting of the value of above-market and
below-market leases, and acquired ground leases, based in each case on their
fair values. Loan premiums, in the case of above market rate assumed loans, or
loan discounts, in the case of below market assumed loans, are recorded based on
the fair value of any loans assumed in connection with acquiring the real
estate.



The fair values of the tangible assets of an acquired property are determined
based on comparable land sales for land and replacement costs adjusted for
physical and market obsolescence for the improvements. The fair values of the
tangible assets of an acquired property are also determined by valuing the
property as if it were vacant, and the "as-if-vacant" value is then allocated to
land, building and tenant improvements based on management's determination of
the relative fair values of these assets. Management determines the as-if-vacant
fair value of a property based on assumptions that a market participant would
use, which is similar to methods used by independent appraisers. In addition,
there is intangible value related to having tenants leasing space in the
purchased property, which is referred to as in-place lease value. Such value
results primarily from the buyer of a leased property avoiding the costs
associated with leasing the property and also avoiding rent losses and
unreimbursed operating expenses during the hypothetical lease-up period. Factors
considered by management in performing these analyses include an estimate of
carrying costs during the expected lease-up periods considering current market
conditions and costs to execute similar leases. In estimating carrying costs,
management includes real estate taxes, insurance and other operating expenses
and estimates of lost rental revenue during the expected lease-up periods based
on current market demand. Management also estimates costs to execute similar
leases including leasing commissions, tenant improvements, legal and other
related costs. The value of in-place leases are amortized to expense over the
remaining initial terms of the respective leases.



In allocating the fair value of the identified intangible assets and liabilities
of an acquired property, above-market and below-market in-place lease values are
recorded based on the present value (using an interest rate which reflects the
risks associated with the leases acquired) of the difference between (i) the
contractual amounts to be paid pursuant to the in-place leases and
(ii) estimated fair market lease rates from the perspective of a market
participant for the corresponding in-place leases, measured, for above-market
leases, over a period equal to the remaining non-cancelable term of the lease
and, for



                                       34

--------------------------------------------------------------------------------


below-market leases, over a period equal to the initial term plus any below
market fixed rate renewal periods. The capitalized above-market lease values are
amortized as a reduction of rental income over the remaining non-cancelable
terms of the respective leases. The capitalized below-market lease values, also
referred to as acquired lease obligations, are amortized as an increase to
rental income over the initial terms of the respective leases.

Asset Impairment:  We review each of our properties for indicators that its
carrying amount may not be recoverable. Examples of such indicators may include
a significant decrease in the market price of the property, a change in the
expected holding period for the property, a significant adverse change in how
the property is being used or expected to be used based on the underwriting at
the time of acquisition, an accumulation of costs significantly in excess of the
amount originally expected for the acquisition or development of the property,
or a history of operating or cash flow losses of the property. When such
impairment indicators exist, we review an estimate of the future undiscounted
net cash flows (excluding interest charges) expected to result from the real
estate investment's use and eventual disposition and compare that estimate to
the carrying value of the property. We consider factors such as future operating
income, trends and prospects, as well as the effects of leasing demand,
competition and other factors. If our future undiscounted net cash flow
evaluation indicates that we are unable to recover the carrying value of a real
estate investment, an impairment loss is recorded to the extent that the
carrying value exceeds the estimated fair value of the property. The evaluation
of anticipated cash flows is highly subjective and is based in part on
assumptions regarding future occupancy, rental rates and capital requirements
that could differ materially from actual results in future periods. Since cash
flows on properties considered to be long-lived assets to be held and used are
considered on an undiscounted basis to determine whether the carrying value of a
property is recoverable, our strategy of holding properties over the long-term
directly decreases the likelihood of their carrying values not being recoverable
and therefore requiring the recording of an impairment loss. If our strategy
changes or market conditions otherwise dictate an earlier sale date, an
impairment loss may be recognized and such loss could be material. If we
determine that the asset fails the recoverability test, the affected assets must
be reduced to their fair value.



We generally estimate the fair value of rental properties utilizing a discounted
cash flow analysis that includes projections of future revenues, expenses and
capital improvement costs that a market participant would use based on the
highest and best use of the asset, which is similar to the income approach that
is commonly utilized by appraisers. In certain cases, we may supplement this
analysis by obtaining outside broker opinions of value or third party
appraisals.



In considering whether to classify a property as held for sale, we consider
factors such as whether management has committed to a plan to sell the property,
the property is available for immediate sale in its present condition for a
price that is reasonable in relation to its current value, the sale of the
property is probable, and actions required for management to complete the plan
indicate that it is unlikely that any significant changes will made to the
plan. If all the criteria are met, we classify the property as held for sale.
Upon being classified as held for sale, depreciation and amortization related to
the property ceases and it is recorded at the lower of its carrying amount or
fair value less cost to sell. The assets and related liabilities of the property
are classified separately on the consolidated balance sheets for the most recent
reporting period. Only those assets held for sale that constitute a strategic
shift or that will have a major effect on our operations are classified as
discontinued operations.

An other than temporary impairment of an investment in an unconsolidated LLC is
recognized when the carrying value of the investment is not considered
recoverable based on evaluation of the severity and duration of the decline in
value, including projected declines in cash flow. To the extent impairment has
occurred, the excess carrying value of the asset over its estimated fair value
is charged to income.



Federal Income Taxes:  No provision has been made for federal income tax
purposes since we qualify as a REIT under Sections 856 to 860 of the Internal
Revenue Code of 1986, and intend to continue to remain so qualified.  To qualify
as a REIT, we must meet certain organizational and operational requirements,
including a requirement to distribute at least 90% of our annual REIT taxable
income to shareholders. As a REIT, we generally will not be subject to federal,
state or local income tax on income that we distribute as dividends to our
shareholders.

We are subject to a federal excise tax computed on a calendar year basis. The
excise tax equals 4% of the amount by which 85% of our ordinary income plus 95%
of any capital gain income for the calendar year exceeds cash distributions
during the calendar year, as defined. No provision for excise tax has been
reflected in the financial statements as no tax was due.

Earnings and profits, which determine the taxability of dividends to
shareholders, will differ from net income reported for financial reporting
purposes due to the differences for federal tax purposes in the cost basis of
assets and in the estimated useful lives used to compute depreciation and the
recording of provision for investment losses.



                                       35

--------------------------------------------------------------------------------

Results of Operations

Year ended December 31, 2019 as compared to the year ended December 31, 2018:

For the year ended December 31, 2019, net income was $19.0 million as compared to $24.2 million during 2018. The $5.2 million decrease was primarily attributable to:

$4.5 million decrease resulting from the Hurricane Harvey related insurance

recovery proceeds received in excess of property damage write-offs recorded

during 2018;

$1.2 million decrease resulting from the Hurricane Harvey related business

interruption insurance recovery proceeds received recorded during 2018,

including approximately $500,000 which related to 2017;

$1.7 million decrease resulting from the income recorded during 2018 in

connection with a lease termination agreement entered into during the second


      quarter of 2018 related to a single tenant MOB located in Texas that
      terminated a lease that was scheduled to expire in July, 2020;

$2.0 million increase resulting from gains recorded during 2019 related to

the sale of the Kings Crossing II MOB and the sale of a parcel of land;

$600,000 increase related to a short-term lease on a hospital facility

located in Evansville, Indiana (lease term of June 1, 2019 through September

30, 2019), that was entered into at a substantially increased lease rate as

compared to the original lease which expired on May 31, 2019 (the facility

has been vacant since September 30, 2019);

$434,000 decrease resulting from the June 1, 2019 expiration of a lease on a

hospital facility located in Corpus Christi, Texas (the facility has been

vacant since June 1, 2019);

$563,000 increase in bonus rental revenue related to the UHS hospital

facilities, and;

$581,000 of other combined net decreases, including an increase in interest

expense due primarily to increases in our average outstanding borrowings,

and average cost of borrowings, pursuant to our revolving credit agreement.




Total revenues increased $1.0 million, or 1.3%, during 2019 as compared to 2018.
The increase was due primarily to: (i) a $563,000 increase in the bonus rental
revenue generated on the UHS hospital facilities; (ii) a $718,000 increase
resulting from the increased rental rate in connection with a short-term lease
covering the period of June 1, 2019 through September 30, 2019 on a hospital
facility located in Evansville, Indiana, that was vacated on September 30, 2019
(see Hospital Leases below), and; (iii) a $428,000 decrease resulting from the
June 1, 2019 lease expiration and tenant vacancy at a hospital facility located
in Corpus Christi, Texas, (see Hospital Leases below).

Included in our other operating expenses are expenses related to the
consolidated medical office buildings and two vacant hospital facilities (as
discussed herein), which totaled $19.1 million and $18.6 million for the years
ended December 31, 2019 and 2018, respectively. Our operating expenses for 2019
include expenses associated with the lease expirations at two of our hospital
facilities, which are currently vacant, of approximately $370,000 in the
aggregate for the year ended December 31, 2019. A large portion of the expenses
associated with our consolidated medical office buildings is passed on directly
to the tenants either directly as tenant reimbursements of common area
maintenance expenses of included in base rental amounts. Tenant reimbursements
for operating expenses are accrued as revenue in the same period the related
expenses are incurred and are included as tenant reimbursement revenue in our
consolidated statements of income.

During 2019, we had a total of 62 new or renewed leases related to the medical
office buildings as indicated in Item 2. Properties, in which we have
significant investments, some of which are accounted for by the equity method.
These leases comprised approximately 24% of the aggregate rentable square feet
of these properties (17% related to renewed leases and 7% related to new
leases). During 2018, we had a total of 34 new or renewed leases related to the
medical office buildings, in which we have significant investments, some of
which are accounted for by the equity method. These leases comprised
approximately 17% of the aggregate rentable square feet of these properties (14%
related to renewed leases and 3% related to new leases).

Rental rates, tenant improvement costs and rental concessions vary from property
to property based upon factors such as, but not limited to, the current
occupancy and age of our buildings, local overall economic conditions, proximity
to hospital campuses and the vacancy rates, rental rates and capacity of our
competitors in the market. In connection with lease renewals executed during
each year, the weighted-average rental rates, as compared to rental rates on the
expired leases, remained relatively unchanged during 2019 and decreased 3%
during 2018. The weighted-average tenant improvement costs associated with new
or renewed leases was approximately $15 and $10 per square foot during 2019 and
2018, respectively. The weighted-average leasing commissions on the new and
renewed leases commencing during each year was approximately 2% of base rental
revenue over the term of the leases during 2019 and 4% of base rental revenue
over the term of the leases during 2018. The average aggregate value of the
tenant concessions, generally consisting of rent abatements, provided in
connection with new and renewed leases commencing during each year was
approximately 0.4% and 0.5% of the future aggregate base rental revenue over the
lease terms during 2019 and 2018, respectively. Rent abatements were, or will
be, recognized in our results of operations under the straight-line method over
the lease term regardless of when payments are due.



                                       36

--------------------------------------------------------------------------------


Funds from operations ("FFO") is a widely recognized measure of performance for
Real Estate Investment Trusts ("REITs"). We believe that FFO and FFO per diluted
share, which are non-GAAP financial measures, are helpful to our investors as
measures of our operating performance. We compute FFO in accordance with
standards established by the National Association of Real Estate Investment
Trusts ("NAREIT"), which may not be comparable to FFO reported by other REITs
that do not compute FFO in accordance with the NAREIT definition, or that
interpret the NAREIT definition differently than we interpret the definition.
FFO adjusts for the effects of gains, such as gains on transactions and
hurricane recovery proceeds in excess of damaged property write-downs during the
periods presented. We adjusted for hurricane insurance recovery proceeds in
excess of damaged property write-downs for the twelve months of 2018 since we
believe that this gain is similar in nature and has the same characteristics as
an adjustment for gains/losses resulting from the sale of depreciable property,
which are required to be excluded from FFO under NAREIT's definition. To the
extent a REIT recognizes a gain or loss with respect to the sale of incidental
assets, such as the sale of land peripheral to operating properties, the REIT
has the option to exclude or include such gains and losses in the calculation of
FFO. We have opted to exclude gains and losses from sales of incidental assets
in our calculation of FFO. FFO does not represent cash generated from operating
activities in accordance with GAAP and should not be considered to be an
alternative to net income determined in accordance with GAAP. In addition, FFO
should not be used as: (i) an indication of our financial performance determined
in accordance with GAAP; (ii) an alternative to cash flow from operating
activities determined in accordance with GAAP; (iii) a measure of our liquidity,
or; (iv) an indicator of funds available for our cash needs, including our
ability to make cash distributions to shareholders.

Below is a reconciliation of our reported net income to FFO for 2019 and 2018
(in thousands):

                                                            2019             2018
Net income                                              $     18,964     $     24,196

Depreciation and amortization expense on consolidated investments

                                                   25,870        

24,337


Depreciation and amortization expense on
unconsolidated affiliates                                      1,141        

1,036

Hurricane insurance recovery proceeds in excess of damaged property write-downs

                                       -           (4,535 )
Gains on sales of real estate assets                          (1,951 )      

-


Funds From Operations                                   $     44,024     $  

45,034



Weighted average number of shares outstanding -
Diluted                                                       13,752        

13,722


Funds From Operations per diluted share                 $       3.20     $  

3.28





Our FFO decreased $1.0 million, or $.08 per diluted share, during 2019 as
compared to 2018 due primarily to: (i) a decrease of approximately $1.7 million,
or $.12 per diluted share, resulting from a lease termination agreement entered
into during 2018 on a single-tenant medical office building located in Texas
(this agreement terminated a lease that was scheduled to expire in July, 2020);
(ii) a decrease of approximately $500,000, or $.04 per diluted share, resulting
from business interruption insurance recovery proceeds recorded during 2018 that
related to the period of August through December of 2017; (iii) an increase of
approximately $400,000, or $.03 per diluted share, consisting of non-recurring
repairs and remediation expenses incurred during 2018 at one of our medical
office buildings; (iv) an increase of approximately $563,000, or $.04 per
diluted share, resulting from an increase in bonus rent from UHS hospital
facilities, and; (v) other combined net increase of approximately $275,000, or
$.02 per diluted share.



Hurricane Harvey Impact

In late August, 2017, five of our medical office buildings located in the
Houston, Texas area, incurred extensive water damage as a result of Hurricane
Harvey. Until various times during the second quarter of 2018, these properties
were temporarily closed and non-operational as we continued to reconstruct and
restore them to operational condition. As of June 30, 2018, reconstruction on
all of the occupied space in these properties had been completed and operations
had resumed.



During the first quarter of 2018, pursuant to the terms of a global settlement
with our commercial property insurance carrier, we received $5.5 million of
additional insurance recovery proceeds bringing the aggregate hurricane-related
insurance recoveries to $12.5 million. The aggregate insurance recovery
proceeds, which are net of applicable deductibles, covered substantially all of
the costs incurred related to the remediation, repair and reconstruction of each
of these properties as well business interruption recoveries for the lost income
related to each of these properties during the period they were
non-operational.



Included in our financial results for the year ended December 31, 2018 are
hurricane insurance recoveries of approximately $4.5 million consisting of
recovery proceeds in excess of the damaged property write-downs. Additionally,
during 2018, we recorded approximately $1.2 million of hurricane business
interruption insurance recoveries in connection with the damage sustained from
Hurricane Harvey. Included in this amount, which covered the period of late
August, 2017 through the second quarter of 2018 (after satisfaction of the
applicable deductibles), was approximately $500,000 related to the period of
August, 2017 through December, 2017.



                                       37

--------------------------------------------------------------------------------




Included in our financial results for the year ended December 31, 2017 are
hurricane related expenses of approximately $5.0 million consisting of $3.6
million related to property damage and $1.4 million related to remediation and
demolition expenses. Also included in our financial results for the twelve-month
period ended December 31, 2017 are aggregate hurricane related insurance
recoveries of approximately $7.0 million, consisting of $5.0 million related to
recovery of hurricane related expenses and $2.0 million related to recovery
proceeds in excess of the damaged property write-downs.



Hospital Leases



Included in our portfolio are six hospital facilities, including two which are
currently vacant since the leases were not renewed upon expiration of the lease
terms on June 1st and September 30th of 2019. The revenues generated by these
six hospital facilities comprised approximately 26%, 25% and 26% of our
consolidated revenues in 2019, 2018 and 2017, respectively. The combined
revenues generated from the leases on the three UHS hospital facilities, which
have existing lease terms that are scheduled to expire in 2021 (two hospitals)
or 2026 (one hospital), accounted for approximately 22%, 21% and 22% of our
consolidated revenues in 2019, 2018 and 2017, respectively. The combined
revenues generated from the leases on the two hospital facilities vacated during
2019 comprised approximately 2% of our consolidated revenues during each of
2019, 2018 and 2017.

The two hospital facilities which are currently vacant since the expiration of
their leases during 2019 are located in Evansville, Indiana, and Corpus Christi,
Texas. The former tenant in the Evansville, Indiana, hospital entered into a
short-term lease with us, covering the period of June 1, 2019 through September
30, 2019, at a substantially increased lease rate as compared to the original
lease rate. The lease revenue generated from this facility amounted to $1.4
million during the first nine months of 2019 that it was under lease and
occupied, as compared to $714,000 for the year ended December 31, 2018. The
hospital in Corpus Christi, Texas, which has been vacant since June 1, 2019,
generated revenues of $310,000 during 2019 as compared to $738,000 during 2018.

 Although we are in the process of marketing each property for lease to new
tenants, should these properties remain vacant for an extended period of time,
or should we experience decreased lease rates on future leases, as compared to
prior/expired lease rates, or incur substantial renovation costs to make the
properties suitable for other operators/tenants, our future results of
operations could be materially unfavorably impacted.



Year ended December 31, 2018 as compared to the year ended December 31, 2017:

For the year ended December 31, 2018, net income was $24.2 million as compared to $45.6 million during 2017. The $21.4 million decrease was primarily attributable to:

• a $27.2 million decrease due to the gain recorded during the first quarter

of 2017 in connection with our purchase of the minority interest in, and

subsequent divestiture of, the St. Mary's Professional Office Building

("Arlington transaction");

• a $2.5 million increase resulting from the increase in hurricane insurance

recoveries in excess of property damage write-downs recorded during 2018 as

compared to 2017;

• a $1.7 million increase in connection with a lease termination agreement


      entered into during 2018;


   •  a $1.2 million increase resulting from hurricane-related business

interruption insurance recovery proceeds recorded during 2018 (approximately

$500,000 of which related to 2017);

• a $645,000 decrease in equity in income of LLCs, due primarily to the March,

2017 divestiture of St. Mary's Professional Office Building;

• a decrease of approximately $400,000 resulting from non-recurring repairs

and remediation expenses incurred during 2018 at one of our medical office

buildings, and;




   •  other combined net increases of approximately $1.4 million due to the
      increased net income generated at various properties, including the
      properties acquired during 2018 and 2017.


Total revenues increased $3.9 million, or 5.3%, during 2018 as compared to 2017
due primarily to the revenues generated at MOBs acquired during 2018 and 2017,
as well as net increases at various other properties.

Included in our other operating expenses are expenses related to the
consolidated medical office buildings, which totaled $18.6 million and $17.4
million for the years ended December 31, 2018 and 2017, respectively. The
increase in operating expenses during 2018 as compared to 2017 is partially due
to: (i) the newly constructed medical office building which opened in April,
2017, and; (ii) approximately $400,000 of non-recurring repairs and remediation
expenses incurred at one of our medical office buildings. A large portion of the
expenses associated with our consolidated medical office buildings is passed on
directly to the tenants either directly as tenant reimbursements of common area
maintenance expenses of included in base rental amounts. Tenant reimbursements
for



                                       38

--------------------------------------------------------------------------------

operating expenses are accrued as revenue in the same period the related expenses are incurred and are included as tenant reimbursement revenue in our consolidated statements of income.



During 2018, we had a total of 34 new or renewed leases related to the medical
office buildings as indicated in Item 2. Properties, in which we have
significant investments, some of which are accounted for by the equity method.
These leases comprised approximately 17% of the aggregate rentable square feet
of these properties (14% related to renewed leases and 3% related to new
leases). During 2017, we had a total of 38 new or renewed leases related to the
medical office buildings, in which we have significant investments, some of
which are accounted for by the equity method. These leases comprised
approximately 10% of the aggregate rentable square feet of these properties (7%
related to renewed leases and 3% related to new leases).

Rental rates, tenant improvement costs and rental concessions vary from property
to property based upon factors such as, but not limited to, the current
occupancy and age of our buildings, local overall economic conditions, proximity
to hospital campuses and the vacancy rates, rental rates and capacity of our
competitors in the market. The weighted-average tenant improvement costs
associated with new or renewed leases was approximately $10 per square foot
during each of 2018 and 2017. The weighted-average leasing commissions on the
new and renewed leases commencing during each year was approximately 4% of base
rental revenue over the term of the leases during 2018 and 2% of base rental
revenue over the term of the leases during 2017. The average aggregate value of
the tenant concessions, generally consisting of rent abatements, provided in
connection with new and renewed leases commencing during each year was
approximately 0.5% of the future aggregate base rental revenue over the lease
terms during 2018 and approximately 2% of the future aggregate base rental
revenue over the lease terms during 2017. Rent abatements were, or will be,
recognized in our results of operations under the straight-line method over the
lease term regardless of when payments are due. In connection with lease
renewals executed during each year, the weighted-average rental rates, as
compared to rental rates on the expired leases, decreased by approximately 3%
during each of 2018 and 2017.

Below is a reconciliation of our reported net income to FFO for 2018 and 2017
(in thousands):

                                                            2018             2017
Net income                                              $     24,196     $     45,619

Depreciation and amortization expense on consolidated investments

                                                   24,337        

24,598


Depreciation and amortization expense on
unconsolidated affiliates                                      1,036        

1,240


Hurricane insurance recovery proceeds in excess of
damaged property write-downs                                  (4,535 )         (2,033 )
Gain on Arlington transaction                                      -          (27,196 )
Funds From Operations                                   $     45,034     $     42,228

Weighted average number of shares and equivalents
outstanding - Diluted                                         13,722        

13,625


Funds From Operations per diluted share                 $       3.28     $       3.10




Our FFO increased $2.8 million, or $.18 per diluted share, during 2018 as
compared to 2017 due primarily to: (i) an increase of approximately $1.7
million, or $.12 per diluted share, resulting from a lease termination agreement
entered into during 2018 on a single-tenant medical office building located in
Texas (this agreement terminated a lease that was scheduled to expire in July,
2020); (ii) an increase of approximately $500,000, or $.04 per diluted share,
resulting from business interruption insurance recovery proceeds recorded during
2018 that related to the period of August through December of 2018; (iii) a
decrease of approximately $400,000, or $.03 per diluted share, consisting of
non-recurring repairs and remediation expenses incurred during 2018 at one of
our medical office buildings, and; (iv) other combined net increase of
approximately $1.0 million due to the increased net income generated at various
properties, including the properties acquired during 2018 and 2017.



Effects of Inflation



Inflation has not had a material impact on our results of operations over the
last three years. However, since the healthcare industry is very labor intensive
and salaries and benefits are subject to inflationary pressures, as are supply
and other costs, we and the operators of our hospital facilities cannot predict
the impact that future economic conditions may have on our/their ability to
contain future expense increases. Depending on general economic and labor market
conditions, the operators of our hospital facilities may experience unfavorable
labor market conditions, including a shortage of nurses which may cause an
increase in salaries, wages and benefits expense in excess of the inflation
rate. Their ability to pass on increased costs associated with providing
healthcare to Medicare and Medicaid patients is limited due to various federal,
state and local laws which have been enacted that, in certain cases, limit their
ability to increase prices. Therefore, there can be no assurance that these
factors will not have a material adverse effect on the future results of
operations of the operators of our facilities which may affect their ability to
make lease payments to us.

Most of our leases contain provisions designed to mitigate the adverse impact of inflation. Our hospital leases require all building operating expenses, including maintenance, real estate taxes and other costs, to be paid by the lessee. In addition, certain of


                                       39

--------------------------------------------------------------------------------


the hospital leases contain bonus rental provisions, which require the lessee to
pay additional rent to us based on increases in the revenues of the facility
over a base year amount. In addition, most of our MOB leases require the tenant
to pay an allocable share of operating expenses, including common area
maintenance costs, insurance and real estate taxes. These provisions may reduce
our exposure to increases in operating costs resulting from inflation. To the
extent that some leases do not contain such provisions, our future operating
results may be adversely impacted by the effects of inflation.

Liquidity and Capital Resources

Year ended December 31, 2019 as compared to December 31, 2018:

Net cash provided by operating activities

Net cash provided by operating activities was $42.7 million during 2019 as compared to $42.9 million during 2018. The $275,000 decrease was attributable to:

• an unfavorable change of approximately $1.6 million due to a decrease in

net income plus/minus the adjustments to reconcile net income to net cash

provided by operating activities (depreciation and amortization,

amortization of debt premium, stock-based compensation, hurricane insurance

recovery proceeds in excess of damaged property write-downs and gains on

sales of real estate assets), as discussed above. This decrease was due

primarily to $1.7 million of income recorded during 2018 in connection a


       lease termination agreement on a single-tenant MOB located in Texas, that
       terminated a lease that was scheduled to expire in July, 2020;

• an unfavorable change of $1.8 million in tenant reserves, deposits and

deferred and prepaid rents, primarily resulting from cash received in 2018


       from various tenants as reimbursement for their share of the cost of
       certain tenant improvements;


  • a favorable change of $711,000 in lease and other receivables;


  • a favorable change of $299,000 in leasing costs paid;


    •  a favorable change of $1.3 million in accrued expenses and other
       liabilities due to timing of disbursements, and;


  • other combined net favorable changes of $796,000.



Net cash used in investing activities

Net cash used in investing activities was $16.5 million during 2019 as compared to $8.0 million during 2018.

2019:

During 2019, $16.5 million of net cash was used in investing activities as follows:

• spent $2.1 million to fund equity investments in unconsolidated LLCs/LPs,


        including $1.6 million related to the construction costs for the Texoma
        Medical Plaza II located in Denison, Texas, that is currently being
        constructed;

• spent approximately $12.3 million for capital additions to real estate

investments including $5.9 million related to a new 108-bed behavioral

health care hospital located in Clive, Iowa, that is under construction,

as well as tenant improvements at various MOBs;

• spent approximately $5.1 million to acquire the Bellin Health Family

Medicine Center, as discussed in Note 3 to the consolidated financial

statements - New Construction, Acquisitions, Dispositions and Property

Exchange Transaction;

• received $318,000 of cash distributions in excess of income received from

our unconsolidated LLCs ($2.1 million of cash distributions received less

$1.8 million of equity in income of unconsolidated LLCs), and;

• received approximately $2.8 million of combined cash proceeds from the

sales of real estate assets consisting of an MOB located in Kingwood,

Texas, and a parcel of land.

2018:

During 2018, $8.0 million of net cash was used in investing activities as follows:

• spent $820,000 to fund equity investments in various unconsolidated LLCs;

• spent approximately $8.3 million for additions to real estate investments,


        consisting primarily of hurricane related repairs at certain MOBs and
        tenant improvements at various MOBs;




                                       40

--------------------------------------------------------------------------------

• spent approximately $4.1 million to acquire the Beaumont Medical Sleep

Center Building, as discussed in Note 3 to the consolidated financial

statements - New Construction, Acquisitions, Dispositions and Property


        Exchange Transaction;


  • spent $192,000 for hurricane related remediation expenses;

• received $834,000 of cash distributions in excess of income received from

our unconsolidated LLCs ($2.6 million of cash distributions received less

$1.8 million of equity in income of unconsolidated LLCs), and;

• received approximately $4.5 million of hurricane insurance proceeds in


        excess of damaged property write-downs.



Net cash used in financing activities

Net cash used in financing activities was $25.1 million during 2019, as compared to $33.3 million during 2018.

2019:

The $25.1 million of cash used in financing activities during 2019 consisted of:

• received $16.6 million of additional net borrowings on our revolving line

of credit;

• received $211,000 of net cash from the issuance of shares of beneficial

interest;

• paid $221,000 to repurchase shares of our common stock in connection with

income tax withholding obligations related to stock-based compensation;




  • paid $37.4 million of dividends;


     •  paid $4.2 million on mortgage notes payable that are non-recourse to us,
        including the repayment of $2.5 million related to a previously
        outstanding mortgage note payable on one property that was funded
        utilizing borrowings under our revolving credit agreement, and;


  • paid $35,000 of financing costs

2018:

The $33.3 million of cash used in financing activities during 2018 consisted of:

• received $15.4 million of additional net borrowings on our revolving line

of credit;

• received $13.0 million of proceeds related to a new mortgage note payable

refinancing that are non-recourse to us (these proceeds were utilized to

repay outstanding borrowings under our revolving credit facility);

• received $229,000 of net cash from the issuance of shares of beneficial


        interest;


  • paid $36.8 million of dividends;

• repaid $23.4 million on mortgage notes payable that are non-recourse to us


        (one of which was subsequently refinanced with a new $13.0 million
        mortgage), and;


     •  paid $1.7 million of financing costs related to the revolving credit
        agreement and a new mortgage note payable that is non-recourse to us.

Year ended December 31, 2018 as compared to December 31, 2017:

Net cash provided by operating activities

Net cash provided by operating activities was $42.9 million during 2018 as compared to $46.0 million during 2017. The $3.1 million decrease was attributable to:

• a favorable change of approximately $3.1 million due to an increase in net

income plus/minus the adjustments to reconcile net income to net cash

provided by operating activities (depreciation and amortization,

amortization of debt premium, stock-based compensation, hurricane insurance

recovery proceeds in excess of damaged property write-downs, hurricane

related expenses and recoveries and gain on Arlington transaction). This

increase included $1.7 million of income recording during 2018 in

connection a lease termination agreement on a single-tenant MOB located in

Texas, that terminated a lease that was scheduled to expire in July, 2020;


    •  an unfavorable change of $3.8 million in tenant reserves, deposits and

deferred and prepaid rents, consisting primarily of $4.6 million received


       in 2017 from a tenant as reimbursement for their share of the cost of
       certain tenant improvements;


  • a favorable change of $384,000 in lease receivable;




                                       41

--------------------------------------------------------------------------------



  • an unfavorable change of $614,000 in leasing costs paid;

• an unfavorable change of $1.3 million in accrued expenses and other


       liabilities due to timing of disbursements, and;


  • other combined net unfavorable changes of approximately $900,000

Net cash (used in)/provided by investing activities



Net cash used in investing activities was $8.0 million during 2018 as compared
to $39.5 million of net cash provided by investing activities during 2017. The
factors contributing to the $8.0 million of net cash used in investing
activities during 2018 are detailed above.

2017:

The $39.5 million of net cash was provided by investing activities during 2017 consisted of:

• spent $532,000 to fund equity investments in various unconsolidated LLCs;

• spent approximately $15.3 million in additions to real estate investments,

including construction costs for the Henderson Medical Plaza MOB (this

property opened in April, 2017), as well as tenant improvements at various

MOBs;

• received $7.0 million of aggregate hurricane related insurance recoveries;

• spent approximately $1.4 million to fund hurricane related remediation


        payments;


     •  spent approximately $9.0 million in connection with the July and

September, 2017 acquisitions of the Health Center of Hamburg and the Las

Palmas FED, respectively, as discussed in Note 3 to the consolidated


        financial statements - New Construction, Acquisitions, Dispositions and
        Property Exchange Transaction;

• spent approximately $7.9 million to acquire the minority interest in a

majority-owned LLC (Arlington Medical Properties, LLC);

• received $65.2 million of net cash proceeds (net of closing costs)

generated in connection with the divestiture of St. Mary's Professional

Office Building, as discussed in Note 3 to the consolidated financial

statements - New Construction, Acquisitions, Dispositions and Property

Exchange Transaction;

• received $216,000 of installment repayments in connection with a member

loan advanced to an LLC, and;

• received $1.2 million of cash distributions in excess of income received

from our unconsolidated LLCs ($3.6 million of cash distributions received


        less $2.4 million of equity in income of unconsolidated LLCs).



Net cash used in financing activities



Net cash used in financing activities was $33.3 million during 2018, as compared
to $86.0 million during 2017. The factors contributing to the $33.3 million of
net cash used in financing activities during 2018 are detailed above.

2017:

The $86.0 million of cash used in financing activities during 2017 consisted of:

• received $22.6 million of proceeds from two new mortgage notes payable


        that are non-recourse to us;


     •  received $9.4 million of net cash from the issuance of shares of
        beneficial interest, including $9.1 million of net cash received in

connection with our at-the-market equity issuance program, as discussed


        below;


  • paid $36.1 million of dividends;

• repaid $20.5 million of net borrowings on our revolving credit agreement;

• repaid $61.0 million on mortgage notes payable that are non-recourse to

us, including the repayment of an aggregate of $58.5 million of previously


        outstanding mortgage notes payable on six properties that were funded
        utilizing borrowings under our revolving credit agreement (two of which
        were subsequently refinanced with new mortgages aggregating to $22.6
        million), and;

• paid $446,000 of financing costs related to the revolving credit agreement

and new mortgage notes payable that are non-recourse to us.




Pursuant to the terms of our previously outstanding at-the-market equity
issuance program, during the twelve months ended December 31, 2017, there were
127,499 shares issued at an average price of $74.71 per share which generated
approximately $9.1



                                       42

--------------------------------------------------------------------------------

million of net cash proceeds (net of approximately $400,000, consisting of compensation of $238,000 to Merrill Lynch, as well as $162,000 of other various fees and expenses).

Additional cash flow and dividends paid information for 2019, 2018 and 2017:



As indicated on our consolidated statements of cash flows, we generated net cash
provided by operating activities of $42.7 million during 2019, $42.9 million
during 2018 and $46.0 million during 2017. As also indicated on our statements
of cash flows, non-cash expenses including depreciation and amortization
expense, amortization of debt premium, stock-based compensation expense,
hurricane insurance recovery proceeds in excess of damaged property write-downs,
hurricane related expenses and recoveries and gains on transactions (as
applicable), are the primary differences between our net income and net cash
provided by operating activities for each year. In addition, as reflected in the
cash flows from investing activities section, we received $318,000 during 2019,
$834,000 during 2018 and $1.2 million during 2017, of cash distributions in
excess of income from various unconsolidated LLCs which represents our share of
the net cash flow distributions from these entities. These cash distributions in
excess of income represent operating cash flows net of capital expenditures and
debt repayments made by the LLCs.

We therefore generated $43.0 million during 2019, $43.8 million during 2018 and
$47.2 million during 2017, related to the operating activities of our properties
recorded on a consolidated and an unconsolidated basis. We paid dividends of
$37.4 million during 2019, $36.8 million during 2018 and $36.1 million during
2017. During 2019, the $43.0 million of cash generated from the operating
activities of our properties was $5.6 million greater than the $37.4 million of
dividends paid. During 2018, the $43.8 million of cash generated from the
operating activities of our properties was $7.0 million greater than the $36.8
million of dividends paid. During 2017, the $47.2 million of cash generated
related to the operating activities of our properties was approximately $11.1
million greater than that $36.1 million of dividends paid.

As indicated in the cash flows from investing activities and cash flows from
financing activities sections of the statements of cash flows, there were
various other sources and uses of cash during each of the last three years. From
time to time, various other sources and uses of cash may include items such as
investments and advances made to/from LLCs, additions to real estate
investments, acquisitions/divestiture of properties, net borrowings/repayments
of debt, and proceeds generated from the issuance of equity. Therefore, in any
given period, the funding source for our dividend payments is not wholly
dependent on the operating cash flow generated by our properties. Rather, our
dividends as well as our capital reinvestments into our existing properties,
acquisitions of real property and other investments are funded based upon the
aggregate net cash inflows or outflows from all sources and uses of cash from
the properties we own either in whole or through LLCs, as outlined above.

In determining and monitoring our dividend level on a quarterly basis, our
management and Board of Trustees consider many factors in determining the amount
of dividends to be paid each period. These considerations primarily include:
(i) the minimum required amount of dividends to be paid in order to maintain our
REIT status; (ii) the current and projected operating results of our properties,
including those owned in LLCs, and; (iii) our future capital commitments and
debt repayments, including those of our LLCs. Based upon the information
discussed above, as well as consideration of projections and forecasts of our
future operating cash flows, management and the Board of Trustees have
determined that our operating cash flows have been sufficient to fund our
dividend payments. Future dividend levels will be determined based upon the
factors outlined above with consideration given to our projected future results
of operations.

We expect to finance all capital expenditures and acquisitions and pay dividends
utilizing internally generated and additional funds. Additional funds may be
obtained through: (i) borrowings under our existing $300 million revolving
credit agreement (which had $87.0 million of available borrowing capacity, net
of outstanding borrowings as of December 31, 2019);  (ii) borrowings under or
refinancing of existing third-party debt pursuant to mortgage loan agreements
entered into by our consolidated and unconsolidated LLCs/LPs; (iii) the issuance
of equity, and/or; (iv) the issuance of other long-term debt.

We believe that our operating cash flows, cash and cash equivalents, available
borrowing capacity under our revolving credit agreement and access to the
capital markets provide us with sufficient capital resources to fund our
operating, investing and financing requirements for the next twelve months,
including providing sufficient capital to allow us to make distributions
necessary to enable us to continue to qualify as a REIT under Sections 856 to
860 of the Internal Revenue Code of 1986. In the event we need to access the
capital markets or other sources of financing, there can be no assurance that we
will be able to obtain financing on acceptable terms or within an acceptable
time. Our inability to obtain financing on terms acceptable to us could have a
material unfavorable impact on our results of operations, financial condition
and liquidity.

Credit facilities and mortgage debt



Management routinely monitors and analyzes the Trust's capital structure in an
effort to maintain the targeted balance among capital resources including the
level of borrowings pursuant to our $300 million revolving credit agreement, the
level of borrowings



                                       43

--------------------------------------------------------------------------------


pursuant to non-recourse mortgage debt secured by the real property of our
properties and our level of equity including consideration of additional equity
issuances. This ongoing analysis considers factors such as the current debt
market and interest rate environment, the current/projected occupancy and
financial performance of our properties, the current loan-to-value ratio of our
properties, the Trust's current stock price, the capital resources required for
anticipated acquisitions and the expected capital to be generated by anticipated
divestitures. This analysis, together with consideration of the Trust's current
balance of revolving credit agreement borrowings, non-recourse mortgage
borrowings and equity, assists management in deciding which capital resource to
utilize when events such as refinancing of specific debt components occur or
additional funds are required to finance the Trust's growth.

On March 27, 2018, we entered into a revolving credit agreement ("Credit
Agreement") which, among other things, increased our borrowing capacity by $50
million to $300 million and extended the maturity date from our previously
existing facility. The replacement Credit Agreement, which is scheduled to
mature in March, 2022, includes a $40 million sublimit for letters of credit and
a $30 million sub limit for swingline/short-term loans. The Credit Agreement
also provides for options to extend the maturity date for two additional six
month periods. Additionally, the Credit Agreement includes an option to increase
the total facility borrowing capacity up to an additional $50 million, subject
to lender agreement. Borrowings under the Credit Agreement are guaranteed by
certain subsidiaries of the Trust. In addition, borrowings under the Credit
Agreement are secured by first priority security interests in and liens on all
equity interests in certain of the Trust's wholly-owned subsidiaries. Borrowings
made pursuant to the Credit Agreement will bear interest, at our option, at one,
two, three, or six month LIBOR plus an applicable margin ranging from 1.10% to
1.35% or at the Base Rate plus an applicable margin ranging from 0.10% to 0.35%.
The Credit Agreement defines "Base Rate" as the greater of: (a) the
administrative agent's prime rate; (b) the federal funds effective rate plus 1/2
of 1%, and; (c) one month LIBOR plus 1%. A facility fee of 0.15% to 0.35% will
be charged on the total commitment of the Credit Agreement. The margins over
LIBOR, Base Rate and the facility fee are based upon our total leverage
ratio. At December 31, 2019, the applicable margin over the LIBOR rate was 1.2%,
the margin over the Base Rate was 0.2%, and the facility fee was 0.20%.

At December 31, 2019, we had $213.0 million of outstanding borrowings under our
Credit Agreement and $87.0 million of available borrowing capacity. The carrying
amount and fair value of borrowings outstanding pursuant to the Credit Agreement
was $213.0 million at December 31, 2019. There are no compensating balance
requirements. The average amount outstanding under our Credit Agreement during
the years ended December 31, 2019, 2018 and, 2017 was $198.3 million, $191.4
million and $182.4 million, respectively, with corresponding effective interest
rates of 3.7%, 3.5% and 2.8%, respectively, including commitment fees.

The Credit Agreement contains customary affirmative and negative covenants,
including limitations on certain indebtedness, liens, acquisitions and other
investments, fundamental changes, asset dispositions and dividends and other
distributions. The Credit Agreement also contains restrictive covenants
regarding the Trust's ratio of total debt to total assets, the fixed charge
coverage ratio, the ratio of total secured debt to total asset value, the ratio
of total unsecured debt to total unencumbered asset value, and minimum tangible
net worth, as well as customary events of default, the occurrence of which may
trigger an acceleration of amounts outstanding under the Credit Agreement. We
are in compliance with all of the covenants at December 31, 2019 and 2018. We
also believe that we would remain in compliance if the full amount of our
commitment was borrowed.

The following table includes a summary of the required compliance ratios at
December 31, 2019 and 2018, giving effect to the covenants contained in the
Credit Agreements in effect on the respective dates (dollar amounts in
thousands):



                            December 31, 2019           December 31, 2018
                        Covenant         UHT        Covenant         UHT
Tangible net worth      $ 125,000     $ 167,181     $ 125,000     $ 181,203
Total leverage               < 60 %        42.3 %        < 60 %        41.3 %
Secured leverage             < 30 %         9.1 %        < 30 %         9.8 %
Unencumbered leverage        < 60 %        38.5 %        < 60 %        37.6 %
Fixed charge coverage     > 1.50x          4.0x       > 1.50x          4.3x






                                       44

--------------------------------------------------------------------------------


As indicated on the following table, we have various mortgages, all of which are
non-recourse to us and are not cross-collateralized, included on our
consolidated balance sheet as of December 31, 2019 and 2018 (amounts in
thousands):



                                                            As of 12/31/2019                          As of 12/31/2018
                                                                               Outstanding              Outstanding
                                           Interest         Maturity             Balance                  Balance
Facility Name                                Rate             Date          (in thousands)(a.)         (in thousands)
Corpus Christi, TX, fixed rate mortgage
loan (b.)                                       6.50 %        July, 2019   $                  -      $            2,519
700 Shadow Lane and Goldring MOBs fixed
rate
  mortgage loan                                 4.54 %        June, 2022                  5,654                   5,861
BRB Medical Office Building fixed rate
mortgage loan                                   4.27 %    December, 2022                  5,721                   5,928
Desert Valley Medical Center fixed rate
mortgage loan                                   3.62 %     January, 2023                  4,661                   4,806
2704 North Tenaya Way fixed rate
mortgage loan                                   4.95 %    November, 2023                  6,727                   6,871
Summerlin Hospital Medical Office
Building III fixed
  rate mortgage loan                            4.03 %       April, 2024                 13,196                  13,198
Tuscan Professional Building fixed rate
mortgage loan                                   5.56 %        June, 2025                  3,492                   4,020
Phoenix Children's East Valley Care
Center fixed rate
  mortgage loan                                 3.95 %     January, 2030                  8,961                   9,194
Rosenberg Children's Medical Plaza
fixed rate mortgage loan                        4.42 %   September, 2033                 12,732                  12,948
Total, excluding net debt premium and
net financing fees                                                                       61,144                  65,345
  Less net financing fees                                                                  (594 )                  (711 )
  Plus net debt premium                                                                     194                     247
Total mortgage notes payable,
non-recourse to us, net                                                    $             60,744      $           64,881



(a.) All mortgage loans require monthly principal payments through maturity and


        either fully amortize or include a balloon principal payment upon
        maturity.

(b.) On April 2, 2019, the $2.5 million fixed rate mortgage loan on Corpus

Christi, TX, was fully repaid utilizing borrowings under our Credit

Agreement.




The mortgages are secured by the real property of the buildings as well as
property leases and rents. The mortgages outstanding as of December 31, 2019 had
a combined carrying value of $61.1 million and a combined fair value of
approximately $63.1 million. At December 31, 2018, we had various mortgages, all
of which were non-recourse to us, included in our consolidated balance
sheet. The combined outstanding balance of these various mortgages was $65.3
million and these mortgages had a combined fair value of approximately $64.9
million.

The fair value of our debt was computed based upon quotes received from
financial institutions. We consider these to be "Level 2" in the fair value
hierarchy as outlined in the authoritative guidance for disclosures in
connection with debt instruments. Changes in market rates on our fixed rate debt
impacts the fair value of debt, but it has no impact on interest incurred or
cash flow.

Contractual Obligations:

The following table summarizes the schedule of maturities of our outstanding
borrowing under our revolving credit facility ("Credit Agreement"), the
outstanding mortgages applicable to our properties recorded on a consolidated
basis and our other contractual obligations as of December 31, 2019 (amounts in
thousands):



                                                   Payments Due by Period (dollars in thousands)
                                                    Less than                                      More than
Debt and Contractual Obligation         Total         1 Year       2-3 years       4-5 years        5 years
Long-term non-recourse debt-fixed
(a) (b)                               $  61,144     $    1,913     $   14,278     $    25,442     $    19,511
Long-term debt-variable (c)             212,950              -        212,950               -               -
Estimated future interest payments
on debt outstanding as
  of December 31, 2019 (d)               29,555          8,922         12,620           2,735           5,278
Operating leases (e)                     27,842            480            960             960          25,442

Construction commitments (f)             45,981         45,981              -               -               -
Equity and debt financing
commitments (g)                             362            362              -               -               -
Total contractual obligations         $ 377,834     $   57,658     $  240,808     $    29,137     $    50,231






                                       45

--------------------------------------------------------------------------------

(a) The mortgages are secured by the real property of the buildings as well as

property leases and rents. Property-specific debt is detailed above.

(b) Consists of non-recourse debt with an aggregate fair value of approximately

$63.1 million as of December 31, 2019. Changes in market rates on our fixed

rate debt impacts the fair value of debt, but it has no impact on interest

incurred or cash flow. Excludes $26.6 million of combined third-party debt


    outstanding as of December 31, 2019, that is non-recourse to us, at the
    unconsolidated LLCs in which we hold various non-controlling ownership
    interests (see Note 8 to the consolidated financial statements).

(c) Consists of $213.0 million of borrowings outstanding as of December 31, 2019


    under the terms of our $300 million Credit Agreement which matures on
    March 28, 2022. The amount outstanding approximates fair value as of
    December 31, 2019.

(d) Assumes that all debt outstanding as of December 31, 2019, including

borrowings under the Credit Agreement, and the loans which are non-recourse

to us, remain outstanding until the stated maturity date of the debt

agreements at the same interest rates which were in effect as of December 31,

2019. We have the right to repay borrowings under the Credit Agreement at any

time during the term of the agreement, without penalty. Interest payments are

expected to be paid utilizing cash flows from operating activities or

borrowings under our revolving Credit Agreement.

(e) Reflects our future minimum operating lease payment obligations outstanding

as of December 31, 2019, as discussed in Note 4-Leases to the Consolidated

Financial Statements, in connection with ground leases at fourteen of our

consolidated properties.

(f) Consists of the remaining estimated construction costs of two new

construction projects, consisting of a 108-bed behavioral health care

facility located in Clive, Iowa, and a 75,000 rentable square foot MOB

located in Denison, Texas, both of which are expected to be completed in late

2020. We are required to build these facilities pursuant to agreements with

third parties.

(g) Consists of equity investment and debt financing commitments remaining in

connection with our investment at Forney Medical Plaza II.

Off Balance Sheet Arrangements

As of December 31, 2019, we do not have any off balance sheet arrangements other than equity and debt financing commitments.

Acquisition and Divestiture Activity

Please see Note 3 to the consolidated financial statements for completed transactions.

© Edgar Online, source Glimpses